NCT00013533
- Conditions
- ALL, AML, Bone Marrow Diseases, +21 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Clinical trial condition
Leukemia
Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.
1,702 public trials
178 recruiting studies
Leukemia trial results
NCT00003270
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +57 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT00001623
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +33 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)
NCT00840931
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
- Locations
-
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
NCT00989261
- Conditions
- Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Northwestern Memorial Hospital Chicago, Illinois, United States
- Rush University Medical Center Chicago, Illinois, United States
- Indiana University Indianapolis, Indiana, United States
NCT04187755
- Conditions
- Agranulocytosis, Antibiotic Reaction, Body Temperature Changes, +15 more
- Locations
-
- Cipto Mangunkusumo General Hospital Jakarta Pusat, DKI Jakarta, Indonesia
NCT00185692
- Conditions
- Blood Cancer, CLL, Graft Versus Host Disease, +18 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
Completed
Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT
NCT01012492
- Conditions
- ALL, AML, Anemia, +18 more
- Locations
-
- Boston Children's Hospital Boston, Massachusetts, United States
NCT00052832
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +14 more
- Locations
-
- University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States
Completed
LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT02652871
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States